About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Aspirin Slashes Ovarian Cancer Risk

by Sheela Philomena on October 10, 2012 at 11:15 AM
Font : A-A+

 Aspirin Slashes Ovarian Cancer Risk

Aspirin lowers the risk of serious ovarian cancer - an aggressive carcinoma affecting the surface of the ovary, finds study.

But non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), or other analgesics did not decrease ovarian cancer risk, the study revealed.

Advertisement

Ovarian cancer is the deadliest gynecological malignancy and the fifth-leading cause of death by cancer for women in developed countries.

"Ovarian cancer has a high mortality. Understanding what factors are involved in the development of this disease and investigating preventative interventions for women are vitally important," said lead author Dr. Susanne Kjaer with the Danish Cancer Society Research Center.
Advertisement

"Our study examined the role of analgesics in development of ovarian cancer," she stated.

For the present study, researchers used data from the malignant ovarian cancer (MALOVA) study, a population-based, case-control study investigating this cancer in Danish women between 1995 and 1999. The team analyzed data from 756 women with epithelial ovarian cancer, classified by type of glandular tumors (adenocarcinomas); 447 were serous, 138 were mucinous, and 171 were other types.

A random sample of 1564 women between the ages of 35 and 79 were drawn from the general population as controls. Personal interviews were conducted to determine analgesic drug use.

Findings indicate that women taking aspirin on a regular basis decreased their risk of serous ovarian cancer. Researchers did not find a decrease in ovarian cancer risk in women who regularly used non-aspirin NSAIDs, acetaminophen, or other types of pain relievers.

"Our findings suggest a potential protective effect of analgesic use on ovarian cancer risk, but that benefit should be balanced against adverse effects of pain medication use, such as risk of bleeding and peptic ulcers," Dr. Kjaer concluded.

The researchers recommend that larger studies, which accurately assess dosage, frequency and duration of pain medications, are necessary to understand the impact of analgesic use on ovarian cancer.

The study was published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
COVID Toes
International Yoga Day 2022 - 'Yoga for Humanity'
Wearable Devices Are Now Transforming Depression, Multiple Sclerosis, and Epilepsy Management.
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Ovarian Cancer Cancer and Homeopathy Chemotherapy Chemotherapy Drugs Cancer Facts Cancer Tattoos A Body Art Anticoagulants Healthy Living Reye’s Syndrome 

Most Popular on Medindia

The Essence of Yoga Selfie Addiction Calculator Hearing Loss Calculator Accident and Trauma Care How to Reduce School Bag Weight - Simple Tips Loram (2 mg) (Lorazepam) Color Blindness Calculator Indian Medical Journals Blood Pressure Calculator Sanatogen

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use